WO2009138195A3 - Use of thiophene glycoside derivatives for producing medicaments for treatment of hypertension - Google Patents
Use of thiophene glycoside derivatives for producing medicaments for treatment of hypertension Download PDFInfo
- Publication number
- WO2009138195A3 WO2009138195A3 PCT/EP2009/003311 EP2009003311W WO2009138195A3 WO 2009138195 A3 WO2009138195 A3 WO 2009138195A3 EP 2009003311 W EP2009003311 W EP 2009003311W WO 2009138195 A3 WO2009138195 A3 WO 2009138195A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hypertension
- treatment
- glycoside derivatives
- producing medicaments
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Use of thiophen glycosid derivatives for the production of medicamments for the treatment of hypertension.The invention relates to the use of thiophen glycosid derivatives and their phisiologically acceptable salts for the production of medicamments for the treatment of hypertension.The use of compounds of formula (I), in which the radicals have the stated meanings and their phisiologically acceptable salts for the production of medicamments for the treatment of hypertension is described.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08009089.7 | 2008-05-16 | ||
EP08009089 | 2008-05-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009138195A2 WO2009138195A2 (en) | 2009-11-19 |
WO2009138195A3 true WO2009138195A3 (en) | 2010-01-07 |
Family
ID=39512551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/003311 WO2009138195A2 (en) | 2008-05-16 | 2009-05-11 | Use of thiophene glycoside derivatives for producing medicaments for treatment of hypertension |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009138195A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112142711B (en) * | 2019-06-28 | 2022-03-29 | 中国科学院上海药物研究所 | Substituted thiophene compound, preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003020737A1 (en) * | 2001-09-05 | 2003-03-13 | Bristol-Myers Squibb Company | O-pyrazole glucoside sglt2 inhibitors and method of use |
WO2004007517A1 (en) * | 2002-07-11 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
-
2009
- 2009-05-11 WO PCT/EP2009/003311 patent/WO2009138195A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003020737A1 (en) * | 2001-09-05 | 2003-03-13 | Bristol-Myers Squibb Company | O-pyrazole glucoside sglt2 inhibitors and method of use |
WO2004007517A1 (en) * | 2002-07-11 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2009138195A2 (en) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009016460A8 (en) | Pyrazole compounds and their use as raf inhibitors | |
WO2009145456A3 (en) | Heterocyclic derivatives | |
TN2012000578A1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
EA201100503A1 (en) | GLUCOSIDE DERIVATIVES AND THEIR APPLICATIONS | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
WO2009150137A3 (en) | Pyrazine derivatives as epithelial sodium channel blockers | |
TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
NZ598972A (en) | Spiro-indoline-piperidine derivatives as selective GPR-40 activators for treating diabetes | |
EA201390381A1 (en) | TRIAZINOXADIAZOLES | |
PT2150530E (en) | Substituted sulfonamide derivatives | |
MX2009003382A (en) | Substituted sulfonamide derivatives. | |
IN2012DN03182A (en) | ||
WO2010150211A3 (en) | Use of derivatives of indoles for the treatment of cancer | |
TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
WO2009074247A8 (en) | Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament | |
AU2009306733C1 (en) | Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine | |
GEP20115342B (en) | New diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them | |
NZ597483A (en) | N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives | |
MY165918A (en) | Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof | |
WO2008131946A3 (en) | Substituted amide derivatives | |
WO2010121675A3 (en) | Thiazolyl-benzimidazoles | |
WO2011009533A3 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl derivatives, methods for the production thereof and use thereof for treating diseases | |
MX2012000178A (en) | 2-carboxamide cycloamino ureas useful as pi3k inhibitors. | |
WO2010056644A8 (en) | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands | |
GEP20156244B (en) | New tertiary 8-hydroxyquinoline-7- carboxamide derivatives and usage thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09745529 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09745529 Country of ref document: EP Kind code of ref document: A2 |